P18IN003

CAS No. 71727-40-7

P18IN003( —— )

Catalog No. M34010 CAS No. 71727-40-7

P18IN003 is a selective and effective p18(INK4C) inhibitor that inhibits the activity of p18 protein and can be used to study in vitro expansion of hematopoietic stem cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 235 In Stock
10MG 353 In Stock
25MG 598 In Stock
50MG 759 In Stock
100MG 923 In Stock
200MG Get Quote In Stock
500MG 1841 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    P18IN003
  • Note
    Research use only, not for human use.
  • Brief Description
    P18IN003 is a selective and effective p18(INK4C) inhibitor that inhibits the activity of p18 protein and can be used to study in vitro expansion of hematopoietic stem cells.
  • Description
    P18IN003 is a potent p18(INK4C) inhibitor andspecifically block the activity of p18 protein. P18IN003 has the potential to be aneffective chemical agent for therapeutic expansion of HSC.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    CDK
  • Recptor
    CDK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    71727-40-7
  • Formula Weight
    296.32
  • Molecular Formula
    C17H16N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1NC(=C(N1)C2=CC=C(OC)C=C2)C3=CC=C(OC)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • R-547

    A potent, selective and ATP-competitive CDK inhibitor with Ki of 1/3/1 nM for CDK1/2/4, respectively.

  • CYC065

    CYC065 is a derivative of seliciclib and second generation CDK inhibitor that is mainly active on CDK2/5/9.

  • CDK8-IN-1

    CDK8-IN-1 is a selective CDK8 inhibitor (IC50: 3 nM).